UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Canagliflozin, a novel inhibitor of sodium glucose co‐transporter 2, dose dependently reduces calculated renal threshold for glucose excretion and increases urinary glucose excretion in healthy subjects

Diabetes, obesity & metabolism, 2011-07, Vol.13 (7), p.669-672

2011

Volltextzugriff (PDF)

Canagliflozin, a novel inhibitor of sodium glucose co-transporter 2, dose dependently reduces calculated renal threshold for glucose excretion and increases urinary glucose excretion in healthy subjects

Diabetes, obesity & metabolism, 2011-07, Vol.13 (7), p.669-672

2011

Volltextzugriff (PDF)

Canagliflozin improves glycaemic control over 28 days in subjects with type 2 diabetes not optimally controlled on insulin

Diabetes, obesity & metabolism, 2012-06, Vol.14 (6), p.539-545

2012

Volltextzugriff (PDF)

Preparation, characterization, cytotoxicity and transfection efficiency of poly( dl-lactide-co-glycolide) and poly( dl-lactic acid) cationic nanoparticles for controlled delivery of plasmid DNA

International journal of pharmaceutics, 2007-10, Vol.343 (1), p.247-254

2007

Volltextzugriff (PDF)

Pharmacodynamic effects of canagliflozin, a sodium glucose co-transporter 2 inhibitor, from a randomized study in patients with type 2 diabetes

PloS one, 2014, Vol.9 (9), p.e110069

2014

Volltextzugriff (PDF)

Pharmacokinetics and Pharmacodynamics of a Transdermal Contraceptive Patch and an Oral Contraceptive

Journal of clinical pharmacology, 2007-04, Vol.47 (4), p.497-509

2007

Volltextzugriff (PDF)

Bioequivalence of Canagliflozin/Metformin Immediate Release Fixed- Dose Combination Tablets Compared with Concomitant Administration of Single Components of Canagliflozin and Metformin in Healthy Fed Participants

Journal of bioequivalence & bioavailability, 2014, Vol.6 (6)

Curtin CR, Devineni D

2014

Volltextzugriff (PDF)

Importance of Early Phase Insulin Secretion to Intravenous Glucose Tolerance in Subjects with Type 2 Diabetes Mellitus

The journal of clinical endocrinology and metabolism, 2001-12, Vol.86 (12), p.5824-5829

2001

Volltextzugriff (PDF)

Importance of early phase insulin secretion to intravenous glucose tolerance in subjects with type 2 diabetes mellitus

The journal of clinical endocrinology and metabolism, 2001-12, Vol.86 (12), p.5824-5829

2001

Volltextzugriff (PDF)

Pharmacokinetics of Nateglinide in Renally Impaired Diabetic Patients

Journal of clinical pharmacology, 2003-02, Vol.43 (2), p.163-170

2003

Volltextzugriff (PDF)

Uptake of temozolomide in a rat glioma model in the presence and absence of the angiogenesis inhibitor TNP-470

Cancer research (Chicago, Ill.), 1996-05, Vol.56 (9), p.1983-1987

1996

Volltextzugriff (PDF)

Difficult Scenarios in Cesarean Section

Labour and Delivery, p.563-572

Volltextzugriff (PDF)

Cocaine-induced isolated right ventricular infarction

The American journal of emergency medicine, 2015-07, Vol.33 (7), p.989.e1-989.e3

2015

Volltextzugriff (PDF)

In vivo microdialysis to characterize drug transport in brain tumors : analysis of methotrexate uptake in rat glioma-2 (RG-2)-bearing rats

Cancer chemotherapy and pharmacology, 1996, Vol.38 (6), p.499-507

1996

Volltextzugriff (PDF)

Zalcitabine : clinical pharmacokinetics and efficacy

Clinical pharmacokinetics, 1995-05, Vol.28 (5), p.351-360

1995

Volltextzugriff (PDF)

Tissue distribution of methotrexate following administration as a solution and as a magnetic microsphere conjugate in rats bearing brain tumors

Journal of neuro-oncology, 1995-01, Vol.24 (2), p.143-152

1995

Volltextzugriff (PDF)

Nateglinide, a New Mealtime Glucose Regulator: Lack of Pharmacokinetic Interaction with Digoxin in Healthy Volunteers

Clinical drug investigation, 2000-06, Vol.19 (6), p.465-471

2000

Volltextzugriff (PDF)

Preparation and in vitro Evaluation of Magnetic Microsphere-Methotrexate Conjugate Drug Delivery Systems

Bioconjugate chemistry, 1995-03, Vol.6 (2), p.203-210

1995

Volltextzugriff (PDF)

Intracavitary Hyperthermia: A Newly Designed Applicator for Tracheal Tumors

Medical dosimetry : official journal of the American Association of Medical Dosimetrists, 1988, Vol.13 (3), p.159

1988

Volltextzugriff (PDF)

Intracavitary Hyperthermia: A Newly Designed Applicator for Tracheal Tumors: Endocurietherapy/Hyperthermia Oncology, Vol. 3, No. 1, January 1987, pp. 23–29

Medical dosimetry : official journal of the American Association of Medical Dosimetrists, 1988, Vol.13 (3), p.159-159

1988

Volltextzugriff (PDF)

Effects of Hydrochlorothiazide on the Pharmacokinetics, Pharmacodynamics, and Tolerability of Canagliflozin, a Sodium Glucose Co-transporter 2 Inhibitor, in Healthy Participants

Clinical therapeutics, 2014-05, Vol.36 (5), p.698-710

2014

Volltextzugriff (PDF)

Abstract 12492: Relation of Medical and Social Determinants of Health to Use of Guideline-Directed Medical Therapy for Heart Failure With Reduced Ejection Fraction in the All of Us Research Program

Circulation (New York, N.Y.), 2023-11, Vol.148 (Suppl_1)

2023

Volltextzugriff (PDF)

Abstract 14848: Interplay of Cardiovascular Risk Factors, Comorbidities, Demographics, and Social Determinants of Health on Adherence to Guideline Directed Medical Therapies in Heart Failure With Preserved Ejection Fraction: The All of Us Research Program

Circulation (New York, N.Y.), 2023-11, Vol.148 (Suppl_1)

2023

Volltextzugriff (PDF)

Multi-ancestry GWAS meta-analyses of lung cancer reveal susceptibility loci and elucidate smoking-independent genetic risk

Nature communications, 2024-10, Vol.15 (1), p.8629-13, Article 8629

2024

Volltextzugriff (PDF)

Effect of Hepatic or Renal Impairment on the Pharmacokinetics of Canagliflozin, a Sodium Glucose Co-transporter 2 Inhibitor

Clinical therapeutics, 2015-03, Vol.37 (3), p.610-628.e4

2015

Volltextzugriff (PDF)

1 – 25 von 99

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(78)
Mit Volltextzugriff
(74)

Publikationsform

Sprache

Englisch
(99)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Canagliflozin, a novel inhibitor of sodium glucose co‐transporter 2, dose dependently reduces calculated renal threshold for glucose excretion and increases urinary glucose excretion in healthy subjects

Canagliflozin, a novel inhibitor of sodium glucose co-transporter 2, dose dependently reduces calculated renal threshold for glucose excretion and increases urinary glucose excretion in healthy subjects

Canagliflozin improves glycaemic control over 28 days in subjects with type 2 diabetes not optimally controlled on insulin

Preparation, characterization, cytotoxicity and transfection efficiency of poly( dl-lactide-co-glycolide) and poly( dl-lactic acid) cationic nanoparticles for controlled delivery of plasmid DNA

Pharmacodynamic effects of canagliflozin, a sodium glucose co-transporter 2 inhibitor, from a randomized study in patients with type 2 diabetes

Pharmacokinetics and Pharmacodynamics of a Transdermal Contraceptive Patch and an Oral Contraceptive

Bioequivalence of Canagliflozin/Metformin Immediate Release Fixed- Dose Combination Tablets Compared with Concomitant Administration of Single Components of Canagliflozin and Metformin in Healthy Fed Participants

Importance of Early Phase Insulin Secretion to Intravenous Glucose Tolerance in Subjects with Type 2 Diabetes Mellitus

Importance of early phase insulin secretion to intravenous glucose tolerance in subjects with type 2 diabetes mellitus

Pharmacokinetics of Nateglinide in Renally Impaired Diabetic Patients

Uptake of temozolomide in a rat glioma model in the presence and absence of the angiogenesis inhibitor TNP-470

Difficult Scenarios in Cesarean Section

Cocaine-induced isolated right ventricular infarction

In vivo microdialysis to characterize drug transport in brain tumors : analysis of methotrexate uptake in rat glioma-2 (RG-2)-bearing rats

Zalcitabine : clinical pharmacokinetics and efficacy

Tissue distribution of methotrexate following administration as a solution and as a magnetic microsphere conjugate in rats bearing brain tumors

Nateglinide, a New Mealtime Glucose Regulator: Lack of Pharmacokinetic Interaction with Digoxin in Healthy Volunteers

Preparation and in vitro Evaluation of Magnetic Microsphere-Methotrexate Conjugate Drug Delivery Systems

Intracavitary Hyperthermia: A Newly Designed Applicator for Tracheal Tumors

Intracavitary Hyperthermia: A Newly Designed Applicator for Tracheal Tumors: Endocurietherapy/Hyperthermia Oncology, Vol. 3, No. 1, January 1987, pp. 23–29

Effects of Hydrochlorothiazide on the Pharmacokinetics, Pharmacodynamics, and Tolerability of Canagliflozin, a Sodium Glucose Co-transporter 2 Inhibitor, in Healthy Participants

Abstract 12492: Relation of Medical and Social Determinants of Health to Use of Guideline-Directed Medical Therapy for Heart Failure With Reduced Ejection Fraction in the All of Us Research Program

Abstract 14848: Interplay of Cardiovascular Risk Factors, Comorbidities, Demographics, and Social Determinants of Health on Adherence to Guideline Directed Medical Therapies in Heart Failure With Preserved Ejection Fraction: The All of Us Research Program

Multi-ancestry GWAS meta-analyses of lung cancer reveal susceptibility loci and elucidate smoking-independent genetic risk

Effect of Hepatic or Renal Impairment on the Pharmacokinetics of Canagliflozin, a Sodium Glucose Co-transporter 2 Inhibitor

Suchergebnisse filtern